Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei Gafita

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
AJR. American Journal of Roentgenology|January 15, 2025
Beyond the <i>AJR</i>: PET/CT Using <sup>18</sup>F-PSMA-1007 Is Superior to Multiparametric MRI in Locoregional Staging of Prostate CancersAndrei Gafita, Lilja B Solnes
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Diagnostic Radiopharmaceuticals: A Sustainable Path to the Improvement of Patient CareAndrei Gafita, Andrew R Menard, Lilja B Solnes
PET Clinics|April 26, 2024
Treatment Response Imaging in Prostate CancerMina Swiha, Andrei Gafita, Andrew Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with <sup>177</sup>Lu-PSMA Therapy: A Multicenter Retrospective AnalysisMasatoshi Hotta, Andrei Gafita, Johannes Czernin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2022
Tumor Sink Effect: Myth or Reality?Andrei Gafita, Jeremie Calais, Wolfgang P Fendler, et al.
PET Clinics|May 5, 2024
Prostate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine LearningRobert Seifert, Andrei Gafita, Lilja B Solnes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical TherapyVishnu Murthy, Vinicius Ludwig, Andrei Gafita, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
RECIP 1.0: A Roadmap for Clinical ImplementationAndrei Gafita, Loic Djaileb, Jeremie Calais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
One Hundred Years of the Tracer PrincipleSebastian Hoberück, Klaus Zöphel, Martin G Pomper, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2019
Exceptional 4-year response to <sup>177</sup>Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancerAndrei Gafita, Hui Wang, Robert Tauber, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
AJR. American Journal of Roentgenology|January 15, 2025
Beyond the <i>AJR</i>: PET/CT Using <sup>18</sup>F-PSMA-1007 Is Superior to Multiparametric MRI in Locoregional Staging of Prostate CancersAndrei Gafita, Lilja B Solnes
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Diagnostic Radiopharmaceuticals: A Sustainable Path to the Improvement of Patient CareAndrei Gafita, Andrew R Menard, Lilja B Solnes
PET Clinics|April 26, 2024
Treatment Response Imaging in Prostate CancerMina Swiha, Andrei Gafita, Andrew Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with <sup>177</sup>Lu-PSMA Therapy: A Multicenter Retrospective AnalysisMasatoshi Hotta, Andrei Gafita, Johannes Czernin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2022
Tumor Sink Effect: Myth or Reality?Andrei Gafita, Jeremie Calais, Wolfgang P Fendler, et al.
PET Clinics|May 5, 2024
Prostate-specific Membrane Antigen: Interpretation Criteria, Standardized Reporting, and the Use of Machine LearningRobert Seifert, Andrei Gafita, Lilja B Solnes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2025
The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical TherapyVishnu Murthy, Vinicius Ludwig, Andrei Gafita, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
RECIP 1.0: A Roadmap for Clinical ImplementationAndrei Gafita, Loic Djaileb, Jeremie Calais, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
One Hundred Years of the Tracer PrincipleSebastian Hoberück, Klaus Zöphel, Martin G Pomper, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 6, 2019
Exceptional 4-year response to <sup>177</sup>Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancerAndrei Gafita, Hui Wang, Robert Tauber, et al.
Pageof 10